Rosacea: the battle goes on.
Rosacea presents an enigma to patients and physicians alike. Although new insights and a plethora of therapies provide hope, the underlying etiology remains unknown. This assures a certain amount of frustration as available treatments temporize rather than cure the disease. This article examines the current state of knowledge regarding this fascinating entity.
Landow
Ken
K
Division of Dermatology, Department of Medicine, University of Southern California School of Medicine, Los Angeles, CA, USA. drlandow@lvcm.com
D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D000529:Complementary Therapies; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D004333:Drug Administration Routes; D006801:Humans; D012393:Rosacea / Q000145:classification* / Q000209:etiology / Q000628:therapy*
D000890:Anti-Infective Agents; D003879:Dermatologic Agents